Key facts
- Intravenous ketamine showed higher remission rates than esketamine.
- The study suggests potential advantages of IV ketamine in treatment.
A recent study has found that intravenous ketamine is more effective in achieving remission rates than esketamine. The research indicates that the method of administering ketamine may play a significant role in its therapeutic outcomes. These findings could influence future treatment protocols for conditions where ketamine is used, potentially favoring the intravenous route for enhanced efficacy.